Warning: This security is no longer trading.
defunct
Menlo Therapeutics Inc. (MNLO): Price and Financial Metrics
MNLO Price/Volume Stats
| Current price | $1.35 | 52-week high | $7.48 |
| Prev. close | $1.38 | 52-week low | $1.00 |
| Day low | $1.30 | Volume | 1,561,200 |
| Day high | $1.39 | Avg. volume | 2,817,431 |
| 50-day MA | $1.63 | Dividend yield | N/A |
| 200-day MA | $2.95 | Market Cap | 226.38M |
MNLO Stock Price Chart Interactive Chart >
Menlo Therapeutics Inc. (MNLO) Company Bio
Menlo Therapeutics Inc., a biopharmaceutical company, focuses on the development and commercialization of serlopitant for the treatment of pruritus associated with dermatologic conditions in the United States. The company has completed Phase II clinical trials in pruritus associated with prurigo nodularis. It is also developing products that are in Phase II clinical trials in pruritus associated with psoriasis and atopic dermatitis, and refractory chronic cough. The company was formerly known as Tigercat Pharma, Inc. and changed its name to Menlo Therapeutics Inc. in May 2016. Menlo Therapeutics Inc. was founded in 2011 and is based in Redwood City, California.
MNLO Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | -76.27% |
| YTD | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | 0.00% |
| 2019 | 12.62% |
Loading social stream, please wait...